Answers go deeper than the script: questioning keeps surfacing new concrete detail behind a positive development · compa
The model's full reasoning — Q3 2017 call → NOThe user wants me to evaluate two gates based on the earnings call transcript. Gate 1: Is there a positive, current development where Q&A adds more concrete operating detail than prepared remarks? Gate 2: Is the main positive development something the company itself created and controls, rather than external environment? Let me analyze the transcript. The company is CyberArk, a cybersecurity company. The prepared remarks mention: - Q3 results exceeded guidance - Strong add-on business and new customers - EMEA deals closed that were expected in Q2 - Record number of 7-figure new business customers - Government momentum, U.S. federal record quarter - Conjur community edition launch - Sales organization changes In the Q&A, analysts probe several areas: 1. Competitive landscape - Udi gives general answer about market competition 2. Sales force changes/globalization - Udi talks about Ron as CRO, early innings 3. Conjur/DevOps - Udi talks about community edition launch, selling motion 4. EMEA recovery - Udi says work in progress, doesn't break out Q2 vs Q3 deals 5. 7-figure deals - Udi mentions mix of products, but general 6. Cloud solutions - Udi talks about being early, Conjur acquisition 7. EPM product line - Udi says pleased but doesn't break down numbers 8. Vertical adoption - general discussion Let me look for a specific positive development where Q&A adds substantial new detail. The EMEA recovery - management says deals slipped from Q2 closed in Q3, but when asked how much was Q2 vs Q3, Udi says "we're not breaking out the division." The 7-figure deals - Udi mentions mix of products (EPV, PSM, EPM, AIM, PTA) but this seems like general description. The sales force globalization - Udi says "early innings" but team is working. Conjur - Udi talks about community edition, selling motion, but no specific new operational details. Actually, looking more carefully, the Q&A responses seem to mostly repeat or generalize the prepared remarks. When analysts ask for specifics (like EMEA breakdown), management deflects. When asked about EPM growth, management says "we don't break it down." The prepared remarks already covered the key points: EMEA deals closed, 7-figure deals, federal record, Conjur launch, sales reorganization. In Q&A, management mostly restates these themes without adding substantial new operational specifics.
The model's full reasoning — Q3 2021 call → NOWe need answer only YES or NO. Need evaluate both gates. Need use transcript. Gate 1: positive current development, Q&A adds more concrete operating detail than prepared remarks. Need identify development. Likely subscription transition/SaaS bookings, Privilege Cloud, EPM, identity security. Prepared remarks already detailed. Q&A: analysts ask about non-Privilege, EPM, cross-sell, federal, etc. Need see if management adds new specifics. Udi gives some specifics: EPM record quarter, new logos examples, federal global government grew >100%, SLED, etc. But are these additive beyond prepared? Prepared already mentioned EPM record, examples. Q&A adds some: federal government vertical grew >100% in Q3, SLED performed well. Also cross-sell motion: PAM customers expand EPM, then secrets management. But is that concrete operating detail? Some. Need determine if multiple exchanges add substantive specifics. There are questions about EPM size, cross-sell, federal. Management answers with generalities and some specifics. However, Gate 1 requires across multiple exchanges, management responses additive with fresh concrete specifics. Let's examine. Prepared remarks: Q3 record SaaS bookings, total bookings, subscription mix 72%, ARR growth, new logos 230, EPM record quarter, examples, Privilege Cloud Fortune 30, identity security, etc. Q&A: Saket asks non-Privilege. Udi says EPM record, Access/DevSecOps speedboats, customers buying wide portfolio, example all products. Not much new. Hamza asks machine-to-machine identity. Udi talks about secrets management, DevOps, no specific numbers. Brian asks Q4 perpetual and transition. Josh explains incentives, pipeline. Jonathan asks EPM size. Udi says opportunity great, awareness, no specifics. Roger asks adaptive customer base. Udi says biggest motion upselling PAM customers on Access/DevSecOps, majority of 7,000 customers. Gregg asks migrations on-prem to SaaS. Udi says incentivize, gradual, examples. Rob asks SaaS driving more users. Udi says classic benefits, faster time to value. Ittai asks perpetual customers. Udi says carrot, maintenance recurring. Catharine asks Zero Trust. Udi says strong drivers, no numbers. Joshua asks PAM vs Access demand. Udi says PAM strongest, Access growing. Taz asks Federal.
The model's full reasoning — Q1 2016 call → NOWe need answer only YES or NO based on transcript. Need evaluate both gates. Let's parse. Gate 1: Positive current development in business, Q&A produces more concrete operating detail than prepared remarks. Need additive specifics. Prepared remarks highlight strong demand, new logos, multi-product deals, Viewfinity momentum, C3 alliance, government growth, etc. Q&A questions: Sterling asks about existing customer follow-on orders/rollout. Udi says majority customer base early innings, strategic approach, pace accelerating in US. Not much concrete. Shaul asks about verticals, law firms, Panama Papers. Udi says law firms example, supply chain effect. Some detail but not much. Gabriela asks about pace of Greenfield, limiting factor. Udi says execution, education, North America most educated, government lagging. Not additive. Saket asks Viewfinity contribution. Josh declines break out, says meaningful, on track, exceeded Avecto resell. Not additive. Jonathan asks multi-product mix, Udi says growth engines, common three, PTA/AIM/Viewfinity. That's some detail but prepared mentioned ~30% new business 3+ products. Q&A gives which products. Maybe not substantial. Jonathan asks mid-size, Udi says greenest Greenfield enterprise focus, Viewfinity mid-market. Not much. Gray asks visibility/sales cycle, Udi says enterprise software typical, volatility. Not specific. Andrew asks billings, no detail. Andrew linearity, no. John asks Q2 guidance, Udi explains no. John asks use case, Udi says customers see program, cloud. Not additive. Catharine asks linearity, no. Kenneth asks channel, Udi gives some detail about hybrid, incentives, partner advisory. Maybe not. Overall, Q&A mostly repeats themes, no deep new specifics. Management answers are general. No concrete operational detail beyond prepared. So Gate 1 likely NO. Need answer NO. But let's see if any positive current development with Q&A additive? Viewfinity? Q&A only says not breaking out, on track. Multi-product? Q&A says common combos. Not enough. C3 alliance not probed. Government? Not probed. No. Thus final NO. Need output exactly YES or NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MNDY | monday.com Ltd. | Q4 2024 | 2024-05-15 | A |
| ZLAB | Zai Lab Limited | Q1 2024 | 2024-05-09 | B |
| YOU | Clear Secure, Inc. | Q1 2024 | 2024-05-08 | C+ |
| STIM | Neuronetics, Inc. | Q1 2024 | 2024-05-07 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q1 2024 | 2024-04-24 | A |
| CSGP | CoStar Group, Inc. | Q1 2024 | 2024-04-23 | B+ |
| SAP | SAP SE | Q1 2024 | 2024-04-22 | B |
| AREC | American Resources Corporation | Q4 2023 | 2024-03-28 | F |
| QRHC | Quest Resource Holding Corporation | Q4 2023 | 2024-03-12 | C+ |
| ALKT | Alkami Technology, Inc. | Q4 2023 | 2024-03-02 | A |
| MCW | Mister Car Wash, Inc. | Q4 2023 | 2024-02-21 | D |
| TYL | Tyler Technologies, Inc. | Q4 2023 | 2024-02-15 | C+ |
| GDDY | GoDaddy Inc. | Q4 2023 | 2024-02-13 | B+ |
| SYY | Sysco Corporation | Q2 2024 | 2024-01-30 | B+ |
| STLD | Steel Dynamics, Inc. | Q4 2023 | 2024-01-24 | C+ |
| CSPI | CSP Inc. | Q4 2023 | 2023-12-12 | D |
| ATXS | Astria Therapeutics, Inc. | Q3 2023 | 2023-11-13 | C |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| VCEL | Vericel Corporation | Q3 2023 | 2023-11-08 | A |
| SG | Sweetgreen, Inc. | Q3 2023 | 2023-11-04 | D |
| CHRD | Chord Energy Corporation | Q3 2023 | 2023-11-02 | A |
| PLTR | Palantir Technologies Inc. | Q3 2023 | 2023-11-02 | B |
| REGN | Regeneron Pharmaceuticals, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| GSK | GSK plc | Q3 2023 | 2023-11-01 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| MNSO | MINISO Group Holding Limited | Q4 2023 | 2023-08-22 | A |
| PFGC | Performance Food Group Company | Q4 2023 | 2023-08-16 | B+ |
| DNUT | Krispy Kreme, Inc. | Q2 2023 | 2023-08-10 | C |
| RBLX | Roblox Corporation | Q2 2023 | 2023-08-09 | C+ |
| PODD | Insulet Corporation | Q2 2023 | 2023-08-08 | B+ |
| MVST | Microvast Holdings, Inc. | Q2 2023 | 2023-08-07 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| CIVI | Civitas Resources, Inc. | Q2 2023 | 2023-08-03 | B |
| IDT | IDT Corporation | Q3 2023 | 2023-06-05 | C |
| STIM | Neuronetics, Inc. | Q1 2023 | 2023-05-13 | B |
| VECO | Veeco Instruments Inc. | Q1 2023 | 2023-05-08 | B |
| LTH | Life Time Group Holdings, Inc. | Q1 2023 | 2023-04-25 | A |
| SCPH | scPharmaceuticals Inc. | Q4 2022 | 2023-03-22 | C+ |
| COCO | The Vita Coco Company, Inc. | Q4 2022 | 2023-03-08 | B |
| PBPB | Potbelly Corporation | Q4 2022 | 2023-03-02 | A |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| LANC | Lancaster Colony Corporation | Q2 2023 | 2023-02-02 | B+ |
| NVS | Novartis AG | Q4 2022 | 2023-02-01 | B |
| RELL | Richardson Electronics, Ltd. | Q2 2023 | 2023-01-05 | B+ |
| CUTR | Cutera, Inc. | Q3 2022 | 2022-11-05 | C |
| MUR | Murphy Oil Corporation | Q3 2022 | 2022-11-03 | B+ |
| LPX | Louisiana-Pacific Corporation | Q3 2022 | 2022-11-01 | B+ |
| INMD | InMode Ltd. | Q3 2022 | 2022-10-27 | B+ |
| INVZ | Innoviz Technologies Ltd | Q2 2022 | 2022-08-10 | D |
| FLGT | Fulgent Genetics, Inc. | Q2 2022 | 2022-08-04 | C+ |
| GTHX | G1 Therapeutics, Inc. | Q1 2022 | 2022-08-03 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| TMUS | T-Mobile US, Inc. | Q2 2022 | 2022-07-27 | B+ |
| AZO | AutoZone, Inc. | Q3 2022 | 2022-05-24 | B+ |
| AXON | Axon Enterprise, Inc. | Q1 2022 | 2022-05-10 | B+ |
| VEV | Vicinity Motor Corp. | Q4 2021 | 2022-03-30 | D |
| HRTX | Heron Therapeutics, Inc. | Q4 2021 | 2022-02-28 | D |
| INCY | Incyte Corporation | Q4 2021 | 2022-02-08 | C+ |
| TMDX | TransMedics Group, Inc. | Q3 2021 | 2021-11-09 | C+ |
| ATRC | AtriCure, Inc. | Q3 2021 | 2021-11-03 | C |
| SUPN | Supernus Pharmaceuticals, Inc. | Q3 2021 | 2021-11-03 | C+ |
| ZI | ZoomInfo Technologies Inc. | Q3 2021 | 2021-11-01 | A |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| CHWY | Chewy, Inc. | Q2 2021 | 2021-09-01 | B |
| VVV | Valvoline Inc. | Q3 2021 | 2021-08-06 | B+ |
| TIGO | Millicom International Cellular S.A. | Q2 2021 | 2021-07-31 | B+ |
| SAP | SAP SE | Q2 2021 | 2021-07-21 | B+ |
| UPWK | Upwork Inc. | Q3 2018 | 2018-11-11 | B+ |
| MYO | Myomo, Inc. | Q3 2018 | 2018-11-05 | C |
| CFG | Citizens Financial Group, Inc. | Q3 2018 | 2018-10-19 | A |
| UAL | United Airlines Holdings, Inc. | Q3 2018 | 2018-10-17 | B+ |
| INSP | Inspire Medical Systems, Inc. | Q2 2018 | 2018-08-12 | A |
| REI | Ring Energy, Inc. | Q2 2018 | 2018-08-09 | B |
| GAIA | Gaia, Inc. | Q2 2018 | 2018-08-06 | B+ |
| RNG | RingCentral, Inc. | Q2 2018 | 2018-08-06 | A |
| FRPT | Freshpet, Inc. | Q2 2018 | 2018-08-06 | B+ |
| TSLA | Tesla, Inc. | Q2 2018 | 2018-08-02 | B |
| OOMA | Ooma, Inc. | Q1 2019 | 2018-05-22 | A |
| ZG | Zillow Group's | Q1 2018 | 2018-05-08 | C+ |
| QLYS | Qualys, Inc. | Q1 2018 | 2018-05-02 | B+ |
| CPS | Cooper-Standard Holdings Inc. | Q1 2018 | 2018-05-02 | B |
| VRTX | Vertex Pharmaceuticals Incorporated | Q1 2018 | 2018-04-26 | C+ |
| SYK | Stryker Corporation | Q1 2018 | 2018-04-26 | B+ |
| TNC | Tennant Company | Q4 2017 | 2018-02-22 | B |
| TMUS | T-Mobile US, Inc. | Q4 2017 | 2018-02-09 | B+ |
| NICE | NICE Ltd. | Q3 2017 | 2017-11-04 | A |
| SAMG | Silvercrest Asset Management Group Inc. | Q3 2017 | 2017-11-03 | A |
| VC | Visteon Corporation | Q3 2017 | 2017-10-28 | B+ |
| PRO | PROS Holdings, Inc. | Q3 2017 | 2017-10-26 | B+ |
| SRPT | Sarepta Therapeutics, Inc. | Q3 2017 | 2017-10-26 | C+ |
| CAL | Caleres, Inc. | Q2 2017 | 2017-08-29 | B+ |
| LITE | Lumentum Holdings Inc. | Q4 2017 | 2017-08-09 | B+ |
| FRPT | Freshpet, Inc. | Q2 2017 | 2017-08-07 | B+ |
| INTU | Intuit Inc. | Q3 2017 | 2017-05-23 | B+ |
| ADAP | Adaptimmune Therapeutics plc | Q1 2017 | 2017-05-10 | D |
| ISDR | Issuer Direct Corporation | Q1 2017 | 2017-05-06 | C |
| XPO | XPO Logistics, Inc. | Q1 2017 | 2017-05-04 | B |
| SRPT | Sarepta Therapeutics, Inc. | Q1 2017 | 2017-04-28 | D |
| SAH | Sonic Automotive, Inc. | Q1 2017 | 2017-04-26 | C |
| SYK | Stryker Corporation | Q4 2016 | 2017-01-24 | C+ |
| MCS | The Marcus Corporation | Q3 2016 | 2016-10-27 | C+ |
| GSK | GSK plc | Q3 2016 | 2016-10-26 | B |
| VYGR | Voyager Therapeutics, Inc. | Q2 2016 | 2016-08-11 | A |
| SQ | Square's | Q2 2016 | 2016-08-04 | A |
| DGII | Digi International Inc. | Q3 2016 | 2016-07-28 | B |
| PAR | PAR Technology Corporation | Q1 2016 | 2016-05-04 | D |
| PM | Philip Morris International Inc. | Q1 2016 | 2016-04-19 | B+ |
RBLX · Q2 2023 → YESThe task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. YES The transcript shows a clear positive current development in advertising, where management's prepared remarks mention live ads, 200 activations, 19% of top 100 with ad units, and some demand exceeding supply. In the Q&A, they add fresh specifics like pricing strategy (gentle now, floating later), new ad unit types, 12% of top 100 using portals, demand in 17-24 female cohort, self-serve options, and brand volume challenges. These details are operational and additive across multiple exchanges, meeting GATE 1 criteria. For GATE 2, advertising is driven by Roblox's own creation and control: 200 activations, portal ad units, self-serve platform, and rollout execution. It's not reliant on external industry tailwinds but on their platform improvements and brand engagement. This satisfies the primary engine condition.
SG · Q3 2023 → YESThe task is to evaluate two gates based on the Sweetgreen earnings call transcript and return YES only if both gates are YES, otherwise NO. YES The transcript shows a clear positive current development in Infinite Kitchen, with management's Q&A responses adding substantial new operational details—such as first-unit performance, customer experience improvements, margin leverage, AUV targeting, retrofit opportunities, and throughput optimizations—that go beyond the prepared remarks' high-level plans. This satisfies Gate 1 criteria for additive, substantive detail across multiple exchanges. For Gate 2, Infinite Kitchen is a proprietary technology the company developed and controls, with momentum driven by its own execution, customer adoption, and operational refinements rather than external tailwinds, making it the primary engine.
ALKT · Q4 2023 → YESThe task is to evaluate two gates based on the earnings call transcript and return YES only if both are YES, otherwise NO. YES The transcript shows a clear positive current development in the bank's market progress and add-on sales momentum, with Q&A providing substantial new operational details like specific backlog numbers, implementation timelines, product adoption rates, and customer-specific challenges that go beyond the prepared remarks. For GATE 2, the primary engine is Alkami's own platform, cloud-native architecture, and execution on replacements of legacy systems, which would largely continue even if external conditions shifted, as the company is actively winning share through its controlled rollout and product improvements.